Structural Aesthetic Treatment With the Hyaluronic Acid Filler VYC ‐ 25L : Global Expert Considerations for Safe and Effective Long‐Term Outcomes
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.16555 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Dario Bertossi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Maxillo Facial Surgery, Head & Neck Department, Università degli Studi di Verona, Verona, Italy. Hauptthemen laut MEDLINE: Hyaluronic Acid, Dermal Fillers, Cosmetic Techniques, Skin Aging. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AbbVie.
Abstract (Originalsprache)
Background
VYC‐25L is a robust, structural hyaluronic acid (HA) filler designed for facial volumizing, lifting, and contouring. It was first approved in 2019.
Methods
A group of doctors with various specialties, who have used VYC‐25L extensively since it first became available in their countries (3–5 years), share clinical experience and guidance on optimal use.
Results
VYC‐25L has a unique rheological and physicochemical profile that provides elevated lift capacity and enhanced projection, significant moldability immediately after injection, high levels of tissue integration, reversibility with hyaluronidase, and a long duration of clinical effects—typically lasting at least 24 months. The properties of VYC‐25L have created new possibilities for nonsurgical facial medical aesthetics. However, as with any novel product, it is important that injectors recognize how best to use it for the benefit of patients. When first utilizing VYC‐25L, it is advisable to start with the chin and jawline to gain familiarity with the gel characteristics before moving into other facial areas, and to consider splitting treatment over two or more sessions. Attention must also be given to injection volume, with less product typically required with VYC‐25L compared to other fillers with similar indications. Key principles of good practice should be followed, including appropriate patient selection and pretreatment education, suitable choice of injection device and plane, aseptic technique, slow and careful administration method, and sufficient posttreatment follow‐up.
Conclusions
By adhering to these principles, VYC‐25L can produce natural‐looking and highly durable outcomes without substantial safety concerns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Maxillo Facial Surgery, Head & Neck Department, Università degli Studi di Verona, Verona, Italy.
- Dr. Denkova Dermatology, Sofia, Bulgaria.
- Anna Hoo Clinic, Kuala Lumpur, Malaysia.
- David Loh Surgery, Singapore, Singapore.
- Knysna Advanced Health Medical Centre, Knysna, South Africa.
- Division of Plastic Surgery, University of Cape Town, Cape Town, South Africa.
ORCID-Profile: Dario Bertossi, Fernando Urdiales-Gálvez
Förderung
- AbbVie
Zitieren
APA
Bertossi, D., Denkova, R., Hoo, A. J. S., Loh, D., Murdoch, M., Shturman Sirota, I., Urdiales-Gálvez, F., de Aguiar Menezes, M. V., & de la Guardia, C. (2025). Structural Aesthetic Treatment With the Hyaluronic Acid Filler VYC ‐ 25L : Global Expert Considerations for Safe and Effective Long‐Term Outcomes. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16555
Vancouver
Bertossi D, Denkova R, Hoo AJS, Loh D, Murdoch M, Shturman Sirota I, et al. Structural Aesthetic Treatment With the Hyaluronic Acid Filler VYC ‐ 25L : Global Expert Considerations for Safe and Effective Long‐Term Outcomes. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.16555
BibTeX
@article{Bertossi2025,
author = {Bertossi, Dario and Denkova, Radina and Hoo, Anna Jen Shi and Loh, David and Murdoch, Marshall and Shturman Sirota, Isaac and Urdiales-Gálvez, Fernando and de Aguiar Menezes, Marcel Vinícius and de la Guardia, Carola},
title = {Structural Aesthetic Treatment With the Hyaluronic Acid Filler VYC ‐ 25L : Global Expert Considerations for Safe and Effective Long‐Term Outcomes},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.16555}
}
EUVIMED